Deutsche Bank’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.55M Buy
186,611
+4,867
+3% +$50.4K ﹤0.01% 1927
2025
Q4
$2.25M Buy
181,744
+1,941
+1% +$20.8K ﹤0.01% 1733
2025
Q3
$1.59M Buy
179,803
+5,173
+3% +$40.2K ﹤0.01% 1910
2025
Q2
$1.11M Buy
174,630
+35,961
+26% +$206K ﹤0.01% 2030
2025
Q1
$674K Hold
138,669
﹤0.01% 2342
2024
Q4
$1.33M Hold
138,669
﹤0.01% 2093
2024
Q3
$1.16M Hold
138,669
﹤0.01% 2048
2024
Q2
$946K Sell
138,669
-20,752
-13% -$89.3K ﹤0.01% 2025
2024
Q1
$403K Sell
159,421
-1,044
-0.7% -$2.35K ﹤0.01% 2457
2023
Q4
$385K Buy
160,465
+136,205
+561% +$320K ﹤0.01% 2509
2023
Q3
$82.5K Sell
24,260
-241,004
-91% -$1.34M ﹤0.01% 3246
2023
Q2
$1.95M Sell
265,264
-13,222
-5% -$123K ﹤0.01% 1635
2023
Q1
$2.89M Buy
278,486
+5,175
+2% +$62.6K ﹤0.01% 1485
2022
Q4
$3.23M Sell
273,311
-125,282
-31% -$1.94M ﹤0.01% 1406
2022
Q3
$8.37M Sell
398,593
-4,935
-1% -$137K 0.01% 1014
2022
Q2
$12.5M Buy
403,528
+22,528
+6% +$769K 0.01% 914
2022
Q1
$15.6M Buy
381,000
+243,115
+176% +$10.7M 0.01% 920
2021
Q4
$5.99M Buy
137,885
+5,501
+4% +$249K ﹤0.01% 1339
2021
Q3
$6.63M Sell
132,384
-785
-0.6% -$47.5K ﹤0.01% 1362
2021
Q2
$8.39M Sell
133,169
-57,435
-30% -$3.69M ﹤0.01% 1259
2021
Q1
$17.7M Sell
190,604
-47,788
-20% -$4.89M 0.01% 941
2020
Q4
$21.4M Buy
238,392
+54,759
+30% +$5.03M 0.01% 774
2020
Q3
$19M Sell
183,633
-32,101
-15% -$3.46M 0.01% 723
2020
Q2
$17.1M Sell
215,734
-10,601
-5% -$790K 0.01% 750
2020
Q1
$13.1M Sell
226,335
-24,185
-10% -$1.39M 0.01% 815
2019
Q4
$13.5M Buy
250,520
+69,143
+38% +$3.75M 0.01% 941
2019
Q3
$9.48M Buy
181,377
+62,138
+52% +$2.89M 0.01% 1096
2019
Q2
$5.76M Sell
119,239
-132,649
-53% -$6.36M ﹤0.01% 1722
2019
Q1
$12.7M Buy
251,888
+152,914
+154% +$9.02M 0.01% 1249
2018
Q4
$5.87M Sell
98,974
-209,199
-68% -$13.5M ﹤0.01% 1648
2018
Q3
$20.3M Sell
308,173
-14,574
-5% -$850K 0.01% 1126
2018
Q2
$16.3M Sell
322,747
-42,860
-12% -$2.23M 0.01% 1330
2018
Q1
$19.2M Buy
365,607
+111,606
+44% +$5.56M 0.01% 1144
2017
Q4
$11.8M Buy
254,001
+82,454
+48% +$3.47M 0.01% 1369
2017
Q3
$6.94M Buy
171,547
+99,774
+139% +$3.61M ﹤0.01% 1699
2017
Q2
$2.43M Buy
71,773
+24,679
+52% +$762K ﹤0.01% 2428
2017
Q1
$1.37M Sell
47,094
-2,716
-5% -$82.7K ﹤0.01% 2464
2016
Q4
$1.63M Sell
49,810
-85,244
-63% -$2.56M ﹤0.01% 2385
2016
Q3
$4.26M Buy
135,054
+15,644
+13% +$455K ﹤0.01% 1847
2016
Q2
$3.35M Buy
119,410
+4,459
+4% +$175K ﹤0.01% 2040
2016
Q1
$4.18M Sell
114,951
-144,159
-56% -$5.09M ﹤0.01% 1862
2015
Q4
$10.4M Buy
259,110
+95,920
+59% +$3.34M 0.01% 1300
2015
Q3
$4.65M Buy
163,190
+44,235
+37% +$1.46M ﹤0.01% 1860
2015
Q2
$3.92M Buy
118,955
+22,400
+23% +$694K ﹤0.01% 1968
2015
Q1
$2.77M Buy
96,555
+12,233
+15% +$351K ﹤0.01% 2200
2014
Q4
$2.29M Buy
84,322
+21,281
+34% +$507K ﹤0.01% 2567
2014
Q3
$1.34M Buy
63,041
+14,530
+30% +$333K ﹤0.01% 2809
2014
Q2
$1.09M Sell
48,511
-51,799
-52% -$1.21M ﹤0.01% 2872
2014
Q1
$2.53M Buy
100,310
+4,158
+4% +$105K ﹤0.01% 2252
2013
Q4
$2.21M Sell
96,152
-27,336
-22% -$570K ﹤0.01% 2232
2013
Q3
$2.35M Buy
123,488
+53,811
+77% +$961K ﹤0.01% 2371
2013
Q2
$1M Buy
+69,677
New +$1.01M ﹤0.01% 2691

Other funds holding EBS